Evidence map›Paper›PMID 35009510›Full record

ArticleMaterials (Basel, Switzerland)2022

Enhanced Metakaolin Reactivity in Blended Cement with Additional Calcium Hydroxide.

Kira Weise, Neven Ukrainczyk, Aaron Duncan, Eduardus Koenders

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kira WeiseInstitute of Construction and Building Materials, Technical University of Darmstadt, 64287 Darmstadt, Germany.ORCID 0000-0002-1604-5153
Neven UkrainczykInstitute of Construction and Building Materials, Technical University of Darmstadt, 64287 Darmstadt, Germany.ORCID 0000-0003-4122-0547
Aaron DuncanInstitute of Construction and Building Materials, Technical University of Darmstadt, 64287 Darmstadt, Germany.ORCID 0000-0002-2667-3444
Eduardus KoendersInstitute of Construction and Building Materials, Technical University of Darmstadt, 64287 Darmstadt, Germany.ORCID 0000-0001-8664-2554

Funding

Deutsche Forschungsgemeinschaft 451894070Federal Ministry for Economic Affairs and Energy KK5027802KI0
6 · The paper itself

Abstract

This study aims to increase the pozzolanic reactivity of metakaolin (MK) in Portland cement (PC) blends by adding additional calcium hydroxide (CH_add) to the initial mixture. Cement paste samples were prepared with PC, MK and water with a water-to-binder ratio of 0.6. Cement replacement ratios were chosen from 5 to 40 wt.% MK. For higher replacement ratios, i.e., 20, 30 and 40 wt.% MK, CH_add was included in the mixture. CH_add-to-MK ratios of 0.1, 0.25 and 0.5 were investigated. Thermogravimetric analysis (TGA) was carried out to study the pozzolanic reactivity after 1, 7, 28 and 56 days of hydration. A modified mass balance approach was used to normalize thermogravimetric data and to calculate the calcium hydroxide (CH) consumption of samples with CH_add. Results showed that, without CH_add, a replacement ratio of 30 wt.% or higher results in the complete consumption of CH after 28 days at the latest. In these samples, the pozzolanic reaction of MK turned out to be restricted by the amount of CH available from the cement hydration. The increased amount of CH in the samples with CH_add resulted in an enhanced pozzolanic reaction of MK as confirmed by CH consumption measurements from TGA.

Indexed as

calcined claycalcium hydroxidemetakaolinpozzolanic reactionsupplementary cementitious materials (SCMs)thermogravimetric analysis (TGA)

Identifiers

PMID35009510
PMCPMC8746242

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.